Prevention and treatment of cerebrospinal fluid leak after translabyrinthine acoustic tumor removal

Otol Neurotol. 2007 Apr;28(3):387-90. doi: 10.1097/01.mao.0000265188.22345.d4.

Abstract

Objective: To determine the incidence rate of cerebrospinal fluid (CSF) leak after translabyrinthine acoustic tumor removal using titanium mesh cranioplasty and to compare with previous series and historical controls.

Study design: Database analysis with historical controls.

Setting: Tertiary referral neurotologic private practice.

Patients: The series of 389 patients who underwent titanium mesh cranioplasty after translabyrinthine tumor removal between March 2003 and July 2005. The results were compared with those in a group of 1,195 translabyrinthine tumor removal patients from our previously published series and with those in a group of 324 patients from the immediately preceding two-year period.

Intervention: Cranioplasty using titanium mesh after acoustic tumor removal.

Main outcome measures: Rates of CSF leak for this method and previous methods of closure.

Results: Thirteen patients (3.3%) had CSF leaks when using the new method of titanium mesh closure. This compares with rates of 10.9% and 8.7% in series in which other methods of closure were used (p < 0.001 and 0.003). The rates of CSF leak requiring reoperation were 0.5%, 2.5%, and 1.9% for the new and the two older series, respectively.

Conclusion: In our hands, titanium mesh cranioplasty seems to reduce the rate of CSF leaks after the translabyrinthine removal of acoustic tumors.

MeSH terms

  • Adult
  • Aged
  • Biocompatible Materials
  • Cerebrospinal Fluid Otorrhea / etiology*
  • Cerebrospinal Fluid Otorrhea / prevention & control*
  • Cerebrospinal Fluid Otorrhea / surgery
  • Cochlear Nerve / pathology*
  • Cochlear Nerve / surgery*
  • Cranial Nerve Neoplasms / pathology*
  • Cranial Nerve Neoplasms / surgery*
  • Ear, Inner / surgery
  • Female
  • Humans
  • Male
  • Middle Aged
  • Otologic Surgical Procedures / methods*
  • Postoperative Complications / prevention & control*
  • Surgical Mesh
  • Titanium / therapeutic use

Substances

  • Biocompatible Materials
  • Titanium